Pharmacy Website
    Clinic Website

    Intelligence » Arthritis » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    Rheumatoid arthritis: How chronic inflammation affects the brain

    Wednesday, June 20, 2018 -- A new study shows how rheumatoid arthritis inflammation affects different brain areas. The findings may explain the cognitive symptoms of the condition.

    New 3D imaging technique could improve arthritis treatment

    Monday, June 18, 2018 -- A team of engineers, physicians and radiologists have developed an algorithm that could change the way that the severity of arthritis is assessed and treated.

    SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

    Tuesday, June 19, 2018 -- SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis

    How does rheumatoid arthritis affect walking ability?

    Wednesday, June 20, 2018 -- Rheumatoid arthritis is a chronic autoimmune disorder that leads to progressive functional impairment. Researchers in Japan assessed factors affecting overall walking ability. Rheumatoid arthritis is a progressive condition in which the body’s immune system mistakenly attacks the joints causing the surrounding tissue to swell and become improperly lubricated. Over time, the cartilage and bone can […] The post How does rheumatoid arthritis affect walking ability? appeared first on Medical News Bulletin | Health News and Medical Research.

    Weight loss of 20% or greater results in better outcomes for overweight, obese adults with knee osteoarthritis

    Monday, June 18, 2018 -- Researchers previously showed that overweight and obese individuals with knee osteoarthritis can reduce pain by 50% and significantly improve function and mobility with a 10% or more weight loss over an 18-month period.

    Cosentyx Slows Progression of Joint Structural Damage in Psoriatic Arthritis

    Wednesday, June 20, 2018 -- The update is based on data from the Phase 3 FUTURE 5 study (N=996) which evaluated Cosentyx versus placebo in patients with active psoriatic arthritis.

    New study examines how the brain plays role in rheumatoid arthritis inflammation

    Monday, June 18, 2018 -- In patients with chronic inflammatory conditions, such as rheumatoid arthritis, there has been limited understanding of how this inflammation affects the brain.

    Studies provide insight into molecular changes prior to onset of arthritis

    Monday, June 18, 2018 -- The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) provide insight into molecular changes prior to the onset of arthritis which could inform future novel diagnostics and early therapeutic interventions.

    SANDOZ: Sandoz presents new long-term and switching data for biosimilars Zessly® (infliximab) and Erelzi® (etanercept) in rheumatoid arthritis

    Wednesday, June 20, 2018 -- Sandoz, a Novartis division and the pioneer and global leader in biosimilars, today announced the presentation of two long-term, Phase III studies: one each for biosimilar Zessly® (infliximab)[4],[5] and biosimilar Erelzi®(etanercept).[6],[7] Read more..

    Gene Signatures from Synovial Fluid Can Predict if Rheumatoid Arthritis Will Progress

    Saturday, June 16, 2018 -- Interview with: Dr. Lisa van Baarsen PhD Principal Investigator at the Amsterdam Rheumatology and Immunology Cente Academic Medical Center the Netherlands What is the background for this study? What are the main findings? Response: The discovery that autoantibodies … Continue reading →

    Number of Joint Replacements Drop in Rheumatoid Arthritis Patients

    Monday, June 18, 2018 -- Interview with: Samuel Hawley | Research Assistant (NIHR PhD Project) | Pharmaco- and Device Epidemiology Group | Centre for Statistics in Medicine | NDORMS | University of Oxford What is the background for this study? What are the main … Continue reading →

    Premature Mortality in Rheumatoid Arthritis Reduced With Early Treatment

    Saturday, June 16, 2018 -- Interview with: Maarten Boers, MSc, MD, PhD Professor of Clinical Epidemiology Department of Epidemiology and Biostatistics VU University Medical Center–F wing MedFac Amsterdam, Netherlands What is the background for this study? What are the main findings? Response: Mortality in rheumatoid arthritis … Continue reading →

    More Weight Loss Linked To Greater Decrease in Knee Arthritis Pain

    Tuesday, June 19, 2018 -- Interview with: Professor Steve Messier Director of the J.B. Snow Biomechanics Laboratory J.B Snow Biomechanics Laboratory Wake Forest University Why did you undertake this study? Response: This was a secondary analysis of the Intensive Diet and Exercise for … Continue reading →

    Tofacitinib May Effectively Alleviate Pain in RA, Psoriatic Arthritis, and Ankylosing Spondylitis

    Wednesday, June 20, 2018 -- Tofacitinib may provide a fast and prolonged analgesic effect in patients with rheumatoid arthritis or psoriatic arthritis who are unresponsive to csDMARD or to TNFi, as well as in individuals with ankylosing spondylitis.

    Zoledronic Acid May Not Improve Knee Osteoarthritis-Related Pain, Function Long-Term

    Thursday, June 21, 2018 -- Zoledronic acid did not significantly reduce knee pain or bone marrow lesion size overall in patients with knee osteoarthritis over 24 months.

    New Recommendations Guide Arthritis Pain Management

    Thursday, June 21, 2018 -- Patient-centered recommendations released by the European League Against Rheumatism

    Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

    Tuesday, June 19, 2018 -- Research from the Department of Inflammation Biology, School of Immunology & Microbial Sciences has shown there is an increased risk of disease flare in Rheumatoid Arthritis patients who suffer from depression.

    Increased Rates of Opioid- and Injection Drug Use-Related Septic Knee Arthritis

    Monday, June 18, 2018 -- The percentage of patients with septic arthritis related to opioid or injection drug use was found to have increased from 2000 to 2013.

    Some Rheumatoid Arthritis Medications Linked to Periodontal Inflammation

    Wednesday, June 20, 2018 -- Rheumatoid arthritis medication is associated with periodontal inflammation without differences in periodontal disease severity.

    Axial Psoriatic Arthritis and Ankylosing Spondylitis: Comparing Clinical, Radiologic Characteristics

    Wednesday, June 20, 2018 -- It is unclear whether ankylosing spondylitis and axial psoriatic arthritis are part of a spectrum of the same disease, or whether they are separate diseases with overlapping features.